Stocks · Korea
058820
KOSDAQ
CMG Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+1.63%
1M-9.79%
3M-40.34%
6M-69.96%
1Y-69.80%
YTD-69.41%
52W high2,205원
52W low—
From 52W high-74.51%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2023 | 939억 | 30억 | 65억 | 3.2% |
| 2024 | 991억 | 10억 | 27억 | 1.0% |
| 2025 | 1,052억 | -37억 | -101억 | -3.5% |
| Quarterly | ||||
| 2024 4Q | -22.8조 | -1,095억 | -2.2조 | — |
| 2025 1Q | 206억 | -13억 | -16억 | -6.5% |
| 2025 2Q | 227억 | -46억 | -109억 | -20.3% |
| 2025 3Q | 304억 | 12억 | 57억 | 4.0% |
| 2025 4Q | 315억 | 10억 | -33억 | 3.3% |
| 2026 1Q | 255억 | -29억 | 1억 | -11.4% |
Company
Address: 서울특별시 강남구 학동로 170 베터라이프빌딩 3층(논현동)
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-06-30주요사항보고서(전환사채권발행결정) Major
- 2026-05-14분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.